RecruitingNCT06332404

Hypoglossal Nerve Stimulation Therapy in Patients With Obstructive Sleep Apnea: Belgian Registry

Hypoglossal Nerve Stimulation (HNS) Therapy in Patients With Obstructive Sleep Apnea (OSA): Belgian Registry


Sponsor

University Hospital, Antwerp

Enrollment

225 participants

Start Date

Apr 18, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

Hypoglossal nerve stimulation (HNS) therapy (Inspire system) is intended for the treatment of patients with moderate to severe obstructive sleep apnea (OSA) who cannot be effectively treated with the first-line treatment options. Recently, the request for reimbursement of the Inspire system in Belgium was approved. The aim is to create a multi-center registry of OSA patients that are treated with HNS (Inspire system) within routine clinical care in Belgium.


Eligibility

Min Age: 18 YearsMax Age: 99 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Hypoglossal nerve stimulation Inspire system (Inspire Medical Systems Inc., USA) for people with apnea, obstructive sleep apnea, and other related conditions. The study is currently recruiting participants at 2 locations.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEHypoglossal nerve stimulation Inspire system (Inspire Medical Systems Inc., USA)

Hypoglossal nerve stimulation therapy


Locations(2)

Antwerp University Hospital

Edegem, Antwerp, Belgium

AZ Sint-Jan Brugge

Bruges, West-Vlaanderen, Belgium

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06332404


Related Trials